Gyre Therapeutics (GYRE) Current Leases (2019 - 2025)
Historic Current Leases for Gyre Therapeutics (GYRE) over the last 7 years, with Q3 2025 value amounting to $626000.0.
- Gyre Therapeutics' Current Leases fell 979.83% to $626000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $626000.0, marking a year-over-year decrease of 979.83%. This contributed to the annual value of $713000.0 for FY2024, which is 23952.38% up from last year.
- Per Gyre Therapeutics' latest filing, its Current Leases stood at $626000.0 for Q3 2025, which was down 979.83% from $622000.0 recorded in Q2 2025.
- In the past 5 years, Gyre Therapeutics' Current Leases ranged from a high of $2.0 million in Q4 2021 and a low of $100000.0 during Q1 2024
- Moreover, its 5-year median value for Current Leases was $686000.0 (2021), whereas its average is $933687.5.
- Its Current Leases has fluctuated over the past 5 years, first plummeted by 7933.84% in 2022, then surged by 70500.0% in 2025.
- Gyre Therapeutics' Current Leases (Quarter) stood at $2.0 million in 2021, then plummeted by 75.11% to $492000.0 in 2022, then plummeted by 57.32% to $210000.0 in 2023, then soared by 239.52% to $713000.0 in 2024, then fell by 12.2% to $626000.0 in 2025.
- Its last three reported values are $626000.0 in Q3 2025, $622000.0 for Q2 2025, and $805000.0 during Q1 2025.